4.8 Article

SORLA regulates endosomal trafficking and oncogenic fitness of HER2

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-10275-0

关键词

-

资金

  1. Academy of Finland
  2. Academy of Finland CoE for Translational Cancer Research
  3. ERC CoG grant [615258]
  4. Sigrid Juselius Foundation
  5. Orion Research Foundation
  6. Finnish Cancer Organization
  7. Turku Doctoral Program of Molecular Medicine (TuDMM)
  8. Finnish Cultural Foundation

向作者/读者索取更多资源

The human epidermal growth factor receptor 2 (HER2) is an oncogene targeted by several kinase inhibitors and therapeutic antibodies. While the endosomal trafficking of many other receptor tyrosine kinases is known to regulate their oncogenic signalling, the prevailing view on HER2 is that this receptor is predominantly retained on the cell surface. Here, we find that sortilin-related receptor 1 (SORLA; SORL1) co-precipitates with HER2 in cancer cells and regulates HER2 subcellular distribution by promoting recycling of the endosomal receptor back to the plasma membrane. SORLA protein levels in cancer cell lines and bladder cancers correlates with HER2 levels. Depletion of SORLA triggers HER2 targeting to late endosomal/lysosomal compartments and impairs HER2-driven signalling and in vivo tumour growth. SORLA silencing also disrupts normal lysosome function and sensitizes anti-HER2 therapy sensitive and resistant cancer cells to lysosome-targeting cationic amphiphilic drugs. These findings reveal potentially important SORLA-dependent endosomal trafficking-linked vulnerabilities in HER2-driven cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience

Liisa Porra, Lauri Wendland, Tiina Seppala, Hanna Koivunoro, Hannu Revitzer, Jussi Tervonen, Leena Kankaanranta, Anu Anttonen, Mikko Tenhunen, Heikki Joensuu

Summary: The authors reviewed the results of 249 patients treated with boron neutron capture therapy (BNCT) at Helsinki University Hospital, Finland. They found that BNCT using l-boronophenylalanine-fructose (l-BPA-F) as the boron delivery agent was well tolerated and showed efficacy in the treatment of head and neck cancer and malignant glioma. They also described a new hospital BNCT facility that integrates a proton accelerator-based neutron source for treatment planning and positioning.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2023)

Article Oncology

Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer

Ke Peng, Feifei Zhang, Yichen Wang, Pranshu Sahgal, Tianxia Li, Jin Zhou, Xiaoyan Liang, Yanxi Zhang, Nilay Sethi, Tianshu Liu, Haisheng Zhang, Adam J. Bass

Summary: The study aims to identify the resistance mechanisms to FAK inhibitors in diffuse gastric cancer (DGC) and evaluate the efficacy of combining FAK inhibitors with CDK4/6 inhibitors or MAPK inhibitors. The results showed that CDK6 promoted resistance to FAK inhibitors and FAK inhibitor treatment activated the MAPK pathway. Furthermore, the combination of CDK4/6 inhibitors or MAPK inhibitors enhanced the efficacy of FAK inhibitors.

CLINICAL CANCER RESEARCH (2023)

Article Oncology

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers

Anna Aakula, Aleksi Isomursu, Christian Rupp, Andrew Erickson, Nikhil Gupta, Otto Kauko, Pragya Shah, Artur Padzik, Yuba Raj Pokharel, Amanpreet Kaur, Song-Ping Li, Lloyd Trotman, Pekka Taimen, Antti Rannikko, Jan Lammerding, Ilkka Paatero, Tuomas Mirtti, Johanna Ivaska, Jukka Westermarck

Summary: This study found that prostate cancer tumors with concomitant inhibition of PP2A and PTEN are particularly aggressive, with low patient survival rates. Overexpression of PME-1 inhibits anoikis in PTEN-deficient prostate cancer cells. The results suggest that PME-1 may be a candidate biomarker for particularly aggressive PTEN-deficient prostate cancer.

MOLECULAR ONCOLOGY (2023)

Article Engineering, Biomedical

Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy

Cameron Wright, Pietari Makela, Alexandre Bigot, Mikael Anttinen, Peter J. Bostrom, Roberto Blanco Sequeiros

Summary: This study aimed to develop a deep learning model capable of predicting the non-perfused volume (NPV) immediately after prostate ablation therapy without the need for MRI contrast agents. The model was trained and tested using MRI imaging data from 95 patients, and the results showed the feasibility of predicting NPV without the use of MRI contrast agents, which could improve patient treatment outcomes.

BIOMEDICAL ENGINEERING LETTERS (2023)

Article Oncology

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, Jochen Schuette, Silke Cameron, Peter Hohenberger, Harri Sihto, Philipp J. Jost, Lars H. Lindner, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Tommi Pesonen, Peter Reichardt

Summary: This study found that patients with KIT exon 11 deletion/indel mutation in gastrointestinal stromal tumor (GIST) had longer overall survival (OS) and recurrence-free survival (RFS) when treated with 3 years of adjuvant imatinib compared to 1 year of treatment. However, patients with KIT exon 9 mutation had poor OS regardless of the duration of adjuvant imatinib treatment.

CLINICAL CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth

Katri Vaparanta, Anne Jokilammi, Ilkka Paatero, Johannes A. Merilahti, Juho Heliste, Karthik Amudhala Hemanthakumar, Riikka Kivela, Kari Alitalo, Pekka Taimen, Klaus Elenius

Summary: In this study, it is demonstrated that Neuregulin-1 (NRG-1) regulates myocardial growth through the STAT5b pathway. Disruption of the NRG-1/ERBB4 pathway or inhibition of Dynamin-2 reduces STAT5b activation and cardiomyocyte hypertrophy. Activation of Stat5 is also observed in NRG-1-induced myocardial growth in zebrafish embryos, and knockdown of stat5b leads to reduced myocardial growth and cardiac function. Furthermore, the NRG-1/ERBB4/STAT5b pathway is differentially regulated in patients with pathological cardiac hypertrophy.

EMBO REPORTS (2023)

Article Biochemistry & Molecular Biology

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer

Kaisa Lehtomaki, Eetu Heerva, Pirkko-Liisa Kellokumpu-Lehtinen, Harri Mustonen, Tapio Salminen, Heikki Joensuu, Kethe Hermunen, Mogens Karsbol Boisen, Julia Sidenius Johansen, Caj Haglund, Pia Osterlund

Summary: Based on the analysis of clinical data from patients with colorectal cancer undergoing adjuvant chemotherapy, it was found that CEA levels transiently increased in about half of the patients during the treatment. Compared to patients with a persistent increase, those with transiently increased CEA had better outcomes in terms of disease-free survival and overall survival.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biology

Impaired fin regeneration and angiogenesis in aged zebrafish and turquoise killifish

Johanna Orling, Katri Kosonen, Jenna Villman, Martin Reichard, Ilkka Paatero

Summary: Impaired wound healing associated with aging has significant impacts on human health and healthcare sector. Deficient angiogenesis may contribute to this process, but the underlying biology is still poorly understood due to complexities and costs in using mammalian aging models. In this study, zebrafish and turquoise killifish fin regeneration models were used to investigate aging-related vascular biology of impaired wound healing. The results showed reduced regeneration in the old individuals of both species, accompanied by changes in angiogenesis, vascular density, and expression levels of angiogenesis biomarker VEGF-A. Anti-angiogenic drug SU5416 further reduced regeneration, suggesting the crucial role of angiogenesis in the regeneration of aging caudal fin despite age-related changes in vasculature. These fish fin regeneration models are therefore suitable for studying aging-related decline in wound healing and associated alterations in aging vasculature.

BIOLOGY OPEN (2023)

Article Dermatology

Eccrine Porocarcinoma: Clinical and Histopathological Study of 14 Patients with Special Emphasis on Sentinel Lymph Node Biopsy

Anna-stiina Merilaeinen, Maria Von Willebrand-Backman, Harri Sihto, Virve Koljonen

Summary: This study retrospectively examined the records of patients with eccrine porocarcinoma and found that there was no significant difference between wide local excision only and wide local excision with sentinel lymph node biopsy groups. Further studies and international collaboration are needed.

ACTA DERMATO-VENEREOLOGICA (2023)

Article Gastroenterology & Hepatology

Genome-Wide Association Study Identifies 4 Novel Risk Loci for Small Intestinal Neuroendocrine Tumors Including a Missense Mutation in LGR5

Anil K. Giri, Mervi Aavikko, Linnea Wartiovaara, Toni Lemmetyinen, Juha Karjalainen, Juha Mehtonen, Kimmo Palin, Niko Valimaki, Max Tamlander, Riikka Saikkonen, Auli Karhu, Ekaterina Morgunova, Benjamin Sun, Heiko Runz, Priit Palta, Shuang Luo, Heikki Joensuu, Tomi P. Makela, Iiro Kostiainen, Camilla Schalin-Jantti, Aarno FinnGen, Aarno Palotie, Lauri A. Aaltonen, Saara Ollila, Mark J. Daly

Summary: This study is the largest genome-wide association study on small intestinal neuroendocrine tumors (SI-NETs) to date, and it identified 6 significant loci associated with SI-NET risk. Four of these loci are novel, and one of the top hits is a missense variant in the LGR5 gene, a marker of adult intestinal stem cells.

GASTROENTEROLOGY (2023)

Article Developmental Biology

Modeling of Zebrafish Housing Temperatures During Power Outage and Instrument Failure

Ilkka Paatero

Summary: Power outages can occur at any time and place for various reasons, posing a threat to scientific research in biology. Aquatic animal husbandry, in particular, is vulnerable as the animals' well-being relies on uninterrupted electricity supply, and years of scientific work may be impacted by the condition of these animal stocks. Therefore, it is crucial to have tools for estimating and managing these risks. This study utilizes modeling to assess temperature changes in aquarium water during power outages and develops simplified models for zebrafish facilities. Additionally, a calculation worksheet is provided to assist in modeling the kinetics of water temperature changes.

ZEBRAFISH (2023)

Article Oncology

Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer

Verneri Virtanen, Kreetta Paunu, Antti Kukkula, Saana Niva, Ylva Junila, Mervi Toriseva, Terhi Jokilehto, Sari Makela, Riikka Huhtaniemi, Matti Poutanen, Ilkka Paatero, Maria Sundvall

Summary: The downregulation of l-CaD, regulated by GR, reduces the metastatic potential of PCa, both in vitro and in vivo. CALD1 gene is co-expressed with GR and GR activation upregulates l-CaD expression. This indicates that l-CaD is involved in PCa metastasis and its expression is clinically relevant in the development of antiandrogen resistance.

ONCOGENESIS (2023)

Review Oncology

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib

Heikki Joensuu

Summary: Gastrointestinal stromal tumor (GIST) is a common sarcoma arising from the gastrointestinal tract, mainly the stomach, with varying malignancy potential. Surgery is generally curative for localized GISTs. Adjuvant imatinib has been shown to improve recurrence-free survival and overall survival (OS) in high-risk GIST patients with an imatinib-sensitive mutation.

CANCERS (2023)

Article Multidisciplinary Sciences

Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors

Pranshu Sahgal, Deepa T. Patil, Pratyusha Bala, Zsofia M. Sztupinszki, Viktoria Tisza, Sandor Spisak, Anna G. Luong, Brandon Huffman, Aurel Prosz, Harshabad Singh, Jean-Bernard Lazaro, Zoltan Szallasi, James M. Cleary, Nilay S. Sethi

Summary: This study found that there is activation of replication stress, DNA damage response (DDR), and p21 in the progression of gastric cancer. Specific DDR biomarkers and ploidy abnormalities can predict the progression of premalignant lesions and the response to DDR pathway inhibitors.

ISCIENCE (2023)

Article Oncology

PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma

Kirsi Toivanen, Sami Kilpinen, Kalle Ojala, Nanna Merikoski, Sami Salmikangas, Mika Sampo, Tom Bohling, Harri Sihto

Summary: By analyzing the RNA sequences and signaling pathways of liposarcoma samples, we identified subtype-specific genes and their expression patterns. PDE3A modulators were found to have potential as drugs for treating myxoid liposarcoma. Further studies are needed to develop these drugs for clinical use.

CANCERS (2023)

暂无数据